HeartBeam Inc (BEAT) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...

By Yahoo! Finance | Nov 8, 2024 at 06:11 PM EST

Net cash used in operating activities was $3.3 million, mostly for R&D and clinical projects. The company aims to secure FDA clearance soon and prepare for an early access program. They plan to manage cash burn prudently and finance the company strategically to align with upcoming milestones.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.